Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 348 (9039), 1407-1413
- https://doi.org/10.1016/s0140-6736(96)04128-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Polymerase chain reaction detection ofTrypanosoma cruziin human blood samples as a tool for diagnosis and treatment evaluationParasitology, 1995
- Chemiluminescent immunoassays: Discrimination between the reactivities of natural and human patient antibodies with antigens from eukaryotic pathogens, Trypanosoma cruzi and Paracoccidioides brasiliensisJournal of Clinical Laboratory Analysis, 1994
- Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up studyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Enfermedad de Chagas congenita en la Ciudad de Salta, ArgentinaRevista do Instituto de Medicina Tropical de São Paulo, 1993
- Use of Trypanosoma cruzi defined proteins for diagnosis-multicentre trial: serological and technical aspectsMemórias do Instituto Oswaldo Cruz, 1990
- Evaluating Interventions against Tropical DiseasesInternational Journal of Epidemiology, 1987
- Inquérito sorológico da prevalência de infecção chagásica no Brasil, 1975/1980Revista do Instituto de Medicina Tropical de São Paulo, 1984
- Criterion of cure of human Chagas' disease after specific chemotherapy: recent advancesMemórias do Instituto Oswaldo Cruz, 1984
- Effect of specific chemotherapy on the levels of lytic antibodies in Chagas's diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- MICROPLATE ENZYME-LINKED IMMUNOSORBENT ASSAY FOR CHAGAS' DISEASEThe Lancet, 1975